Bridge Biotherapeutics, Inc. (KOSDAQ:288330)
South Korea
· Delayed Price · Currency is KRW
742.00
+7.00 (0.95%)
At close: May 28, 2025, 3:30 PM KST
Bridge Biotherapeutics Ratios and Metrics
Market cap in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
| Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| May '25 May 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Market Capitalization | 38,153 | 189,044 | 73,111 | 230,799 | 279,845 | 279,086 | |
| Market Cap Growth | 229.07% | 158.57% | -68.32% | -17.53% | 0.27% | -12.04% | |
| Enterprise Value | 23,844 | 169,078 | 50,708 | 172,628 | 231,285 | 216,852 | |
| Last Close Price | 731.00 | 3750.00 | 2386.14 | 8425.95 | 10314.52 | 10568.76 | |
| Forward PE | - | 9.41 | 9.41 | 9.41 | 9.41 | 9.41 | |
| PS Ratio | 3413.23 | 86794.27 | 731.11 | 76.33 | 145.44 | 44.02 | |
| PB Ratio | 1.61 | 6.86 | 3.53 | 4.45 | 6.50 | 4.71 | |
| P/TBV Ratio | 2.23 | 9.25 | 6.18 | 4.68 | 6.53 | 4.73 | |
| EV/Sales Ratio | - | 77627.28 | 507.08 | 57.09 | 120.20 | 34.20 | |
| Debt / Equity Ratio | 0.10 | 0.10 | 0.17 | 0.06 | 0.01 | 0.01 | |
| Asset Turnover | 0 | 0 | 0.00 | 0.06 | 0.04 | 0.09 | |
| Quick Ratio | 5.15 | 5.70 | 2.01 | 6.97 | 12.23 | 56.55 | |
| Current Ratio | 5.44 | 6.03 | 2.09 | 7.33 | 12.49 | 57.14 | |
| Return on Equity (ROE) | -97.04% | -82.55% | -116.97% | -87.87% | -51.39% | -28.65% | |
| Return on Assets (ROA) | -41.80% | -35.09% | -52.72% | -50.30% | -29.95% | -17.08% | |
| Return on Capital (ROIC) | -50.65% | -43.63% | -63.73% | -55.40% | -32.06% | -18.15% | |
| Earnings Yield | -50.50% | -10.45% | -57.89% | -18.07% | -9.39% | -6.89% | |
| FCF Yield | -44.80% | -10.96% | -43.90% | -17.60% | -7.61% | -4.70% | |
| Buyback Yield / Dilution | -38.11% | -35.66% | -26.02% | -1.56% | -2.53% | -96.53% | |
Source: S&P Global Market Intelligence. Standard template.
Financial Sources.